Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68788-8094

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68788-8094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin Calcium Tablets 40mg (Atorvastatin 40mg 90s Container Label)

Atorvastatin Calcium Tablets 40 mg film-coated oral tablets generic for Lipitor. The label identifies Novadoz Pharmaceuticals LLC as manufacturer, showing warnings, storage instructions, and spaces for lot, batch, and expiration date details. It includes bilingual dosing directions in English and Spanish on a bright yellow background, with a barcode and the Preferred Pharmaceuticals Inc. logo.*

FDA Label Image

Figure-01 (Atorvastatin Figure 01)

A cumulative incidence line graph comparing Atorvastatin and placebo over approximately 3.5 years. The y-axis shows cumulative incidence in percentage, and the x-axis represents time in years. The graph shows a lower cumulative incidence for Atorvastatin compared to placebo, with a hazard ratio (HR) of 0.64 (95% CI 0.50-0.83) and p-value 0.0005 indicated.*

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

A line chart comparing cumulative hazard percentages over time for Atorvastatin versus placebo. The x-axis represents time to first primary endpoint in years, up to 4 years of follow-up, while the y-axis shows cumulative hazard percentage. The Atorvastatin line is solid, showing a lower hazard compared to the placebo dashed line. Statistical data (HR 0.63, p=0.001) is included.*

FDA Label Image

Figure-03 (Atorvastatin Figure 03)

A line chart depicting the time to first major cardiovascular endpoint over five years for subjects taking Atorvastatin 10 mg and 80 mg. The y-axis shows the percentage of subjects experiencing the event, with separate lines for the two doses. The graph includes a hazard ratio (HR 0.78) and p-value (0.0002) indicating statistical analysis results.*

FDA Label Image

Structure (Atorvastatin Structure)

Chemical structure of atorvastatin calcium dihydrate, showing the molecular arrangement including the calcium ion and three water molecules (3H2O). This structure corresponds to the active pharmaceutical ingredient atorvastatin calcium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.